Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pdl Biopharma Inc (PDLI)

Pdl Biopharma Inc (PDLI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 374,527
  • Shares Outstanding, K 114,185
  • Annual Sales, $ 198,110 K
  • Annual Income, $ -68,860 K
  • 60-Month Beta 0.68
  • Price/Sales 3.89
  • Price/Cash Flow 6.09
  • Price/Book 0.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.05
  • Number of Estimates 1
  • High Estimate 0.05
  • Low Estimate 0.05
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.06 +6.54%
on 01/08/20
3.49 -6.72%
on 12/20/19
+0.06 (+1.87%)
since 12/17/19
3-Month
2.36 +38.14%
on 10/18/19
3.68 -11.41%
on 12/09/19
+0.83 (+34.16%)
since 10/17/19
52-Week
2.06 +58.25%
on 10/03/19
3.89 -16.20%
on 04/11/19
+0.08 (+2.52%)
since 01/17/19

Most Recent Stories

More News
Catabasis (CATB) Partners with UK-Based Charity for DMD Study

Catabasis (CATB) teams up with Duchenne UK to fund a phase II study of its pipeline candidate edasalonexent, now being developed to treat patients with non-ambulatory Duchenne muscular dystrophy.

EBS : 55.56 (-0.86%)
PDLI : 3.26 (-0.61%)
CATB : 7.00 (unch)
OBSV : 3.80 (-7.32%)
Watch for Pdl Biopharma In to Potentially Rebound After Falling 2.45% Yesterday

Pdl Biopharma In (NASDAQ:PDLI) traded in a range yesterday that spanned from a low of $3.19 to a high of $3.27. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $3.27...

PDLI : 3.26 (-0.61%)
After Yesterday's Decline of 2.45%, Pdl Biopharma In Offers Investors Better Value

Pdl Biopharma In (NASDAQ:PDLI) traded in a range yesterday that spanned from a low of $3.19 to a high of $3.27. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $3.27...

PDLI : 3.26 (-0.61%)
Pdl Biopharma In Falls 1.32% on Heavy Volume: Watch For Potential Rebound

Pdl Biopharma In (NASDAQ:PDLI) traded in a range yesterday that spanned from a low of $3.30 to a high of $3.42. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $3.32...

PDLI : 3.26 (-0.61%)
Watch for Pdl Biopharma In to Potentially Rebound After Falling 1.32% Yesterday

Pdl Biopharma In (NASDAQ:PDLI) traded in a range yesterday that spanned from a low of $3.30 to a high of $3.42. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $3.32...

PDLI : 3.26 (-0.61%)
PDL BioPharma Announces Upcoming Changes to its Board of Directors

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced upcoming changes to the Company's Board of Directors.

PDLI : 3.26 (-0.61%)
Pdl Biopharma In Set to Possibly Rebound After Yesterday's Selloff of 3.31%

Pdl Biopharma In (NASDAQ:PDLI) traded in a range yesterday that spanned from a low of $3.18 to a high of $3.34. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $3.26...

PDLI : 3.26 (-0.61%)
SmarTrend Watching for Potential Rebound in Shares of Pdl Biopharma In After 3.31% Loss

Pdl Biopharma In (NASDAQ:PDLI) traded in a range yesterday that spanned from a low of $3.18 to a high of $3.34. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $3.26...

PDLI : 3.26 (-0.61%)
PDL BioPharma Board of Directors Increases Share and Note Repurchase Authorization to $275 Million

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced today that its Board of Directors has authorized a $75 million increase to the $200 million common stock and convertible notes repurchase...

PDLI : 3.26 (-0.61%)
PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate, privately negotiated exchange agreements pursuant to which it will exchange $119.3 million...

PDLI : 3.26 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade PDLI with:

Business Summary

Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital...

See More

Key Turning Points

2nd Resistance Point 3.38
1st Resistance Point 3.33
Last Price 3.26
1st Support Level 3.25
2nd Support Level 3.22

See More

52-Week High 3.89
Last Price 3.26
Fibonacci 61.8% 3.19
Fibonacci 50% 2.97
Fibonacci 38.2% 2.76
52-Week Low 2.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar